Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
about
The interplay between the microbiome and the adaptive immune response in cancer developmentNonalcoholic Lipid Accumulation and Hepatocyte Malignant TransformationDietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseasesPaneth cell α-defensins and enteric microbiota in health and diseaseThe Immune Landscape in Nonalcoholic Steatohepatitis.Role of the microbiome in non-gastrointestinal cancersUtilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinomaDiet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetTelomeres, NAFLD and Chronic Liver DiseaseGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsGut microbiota imbalance and colorectal cancerGut Microbiota and Hepatocellular CarcinomaCytoglobin as a Marker of Hepatic Stellate Cell-derived MyofibroblastsThe enteric microbiome in hepatobiliary health and diseaseDysbiotic infection in the stomachEnteral feeding and its impact on the gut immune system and intestinal mucosal barrierNon-autonomous overgrowth by oncogenic niche cells: Cellular cooperation and competition in tumorigenesisXenobiotics: Interaction with the Intestinal MicrofloraWhy does obesity promote cancer? Epidemiology, biology, and open questionsHUMAN MICROBIOTA. Small molecules from the human microbiotaMicrobiology and ecology are vitally important to premedical curriculaCaenorhabditis elegans as a model for cancer researchLessons from mouse models of high-fat diet-induced NAFLDNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerMultifocal epithelial tumors and field cancerization: stroma as a primary determinantMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)Host-microbe interactions in the gut of Drosophila melanogasterGut microbiota and liver diseasesCellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosisThe gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseasesMechanisms linking excess adiposity and carcinogenesis promotionRoles of Sulfur Metabolism and Rhodanese in Detoxification and Anti-Oxidative Stress Functions in the Liver: Responses to Radiation ExposureOf flies, mice, and men: evolutionarily conserved tissue damage responses and agingCross-talk between bile acids and intestinal microbiota in host metabolism and healthLiver ischemic preconditioning (IPC) improves intestinal microbiota following liver transplantation in rats through 16s rDNA-based analysis of microbial structure shiftHost-Microbiome Interaction and Cancer: Potential Application in Precision MedicineThe tumor microenvironment in esophageal cancerGender Differences in Adipocyte Metabolism and Liver Cancer Progression
P2860
Q26745703-5B96886E-E895-4EC8-993E-804F373CA760Q26746521-25D8E9E5-5016-45C0-B155-885EDB6F2979Q26746677-4347C01C-6607-4925-A4B7-5DD1F92AC841Q26747303-8C0EA76F-9EA2-4AD8-91E9-BC5FB27394DFQ26747323-717FAE4C-02DA-4893-BD18-393B402CF9D3Q26747710-64248E11-5537-4901-A961-3EDF40422A26Q26748807-57847EF2-6743-42B9-B6A8-FC2202111992Q26752614-9E14767C-9352-481A-9F7A-E694F1F79D95Q26753037-DAE2F865-03EE-4805-A627-41CE9AE65449Q26753047-6AFB7024-95C3-4A07-90AC-7FC937954C45Q26772302-0B1BB975-D509-490E-952D-758701BFA419Q26774708-2721FD0A-F11F-4850-927C-B80E8D0BE25BQ26775568-75596AFD-AD35-4100-8C19-7869F9347D9DQ26776162-834DA844-D214-4168-AC3B-61E65209E146Q26777426-653B3B54-EBB9-4DDE-A504-181B9C01ECCDQ26777534-015F02CA-9932-45DC-89CA-0439F05DF795Q26777672-C64C4364-CCCE-4F6A-BD94-97B63E03001AQ26781414-C7C24FA7-271E-46A8-991A-C4B8A4815BB9Q26795702-CBE73C05-0ACB-4BDA-AAEA-CB663CD11E15Q26797301-63DBEF84-E477-46C1-AD7B-07299A1EBDE4Q26799980-92804047-8472-4FED-85B8-2393C35BFE49Q26801329-237033D0-7812-48C0-A4EB-1954C56A4CC3Q26828013-BC96B775-116E-4C58-B865-FFA37A07C3D9Q26829532-65D8D511-E3A6-4549-B6FB-54BD68A4ACA6Q26851211-97BD61F0-AB0E-4BAC-9D5B-75F11A844263Q26992106-67855BC0-6462-4707-90E9-18F02C64B6AEQ27005678-2E2D08B6-5A74-47FF-80CF-1343AC9A5952Q27007515-F414A459-A889-4F52-8A86-9FAF480EABFBQ27007557-46640245-97D3-4794-A4CE-4354131B72F2Q27015127-94CF970A-ABBC-485B-9AC0-B3A371588A94Q27021577-FAD662CD-D470-4702-9303-6AAFFCB5A537Q27021692-144C7AD2-D332-4A51-A555-460EBEEEE1BFQ27022929-59B99C2B-E2EC-459B-BD69-26D948FC4F12Q27023286-B94ECB06-BB77-4CB2-8666-DCA48A1B6392Q27025985-3F53331B-34F2-4D18-8DB1-4F62C090F12EQ27026925-D132E1BE-5DC5-47D9-96F2-AF15A4B2CC64Q27305011-1E6EF8CF-1271-4C31-A44C-A56FBA888EB0Q28069401-3F2F788E-3AE4-4282-B503-F960982CC455Q28077074-A48B35E1-1766-4C19-A27E-CDF26F9E90EDQ28078472-3AC47BA6-C56B-4CC5-BD91-66E7E44064CC
P2860
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Obesity-induced gut microbial ...... through senescence secretome.
@en
Obesity-induced gut microbial ...... through senescence secretome.
@nl
type
label
Obesity-induced gut microbial ...... through senescence secretome.
@en
Obesity-induced gut microbial ...... through senescence secretome.
@nl
prefLabel
Obesity-induced gut microbial ...... through senescence secretome.
@en
Obesity-induced gut microbial ...... through senescence secretome.
@nl
P2093
P356
P1433
P1476
Obesity-induced gut microbial ...... through senescence secretome.
@en
P2093
Hidetoshi Morita
Hiroaki Kanda
Kenshiro Oshima
Kenya Honda
Koji Atarashi
Masahira Hattori
Naoko Ohtani
Seidai Sato
Seiichi Oyadomari
P2888
P304
P356
10.1038/NATURE12347
P407
P577
2013-06-26T00:00:00Z
P5875
P6179
1020067445